Table 1. Baseline data of the subjected patients.
| Parameters | Normal (n = 79) | Benign (n = 67) | Epithelial OC (n = 23) | P value |
|---|---|---|---|---|
| Menopause | <0.001 | |||
| No | 64 (81.0) | 52 (77.6) | 9 (39.1) | |
| Yes | 15 (19.0) | 15 (22.4) | 14 (60.9) | |
| Age (yr) | 0.004 | |||
| <50 | 62 (78.5) | 50 (74.6) | 10 (43.5) | |
| ≥ 50 | 17 (21.5) | 17 (25.4) | 13 (56.5) | |
| HE4 (pM/L) (median, range) | ||||
| Overall | 38.9 (15.1-76.6) | 43.7 (14.9-573.4) | 241.8 (35.2-1,808.4) | <0.001 |
| FIGO stage I/II | 100.5 (35.2-312.6) | |||
| FIGO stage III/IV | 467.9 (35.5-1,808.4) | |||
| CA125 (U/mL) (median, range) | ||||
| Overall | 12.8 (2.5-75.3) | 24.2 (5.7-6,629.9) | 153.2 (6.9-6,407.0) | <0.001 |
| FIGO stage I/II | 70.7 (6.9-486.3) | |||
| FIGO stage III/IV | 501.3 (8.7-6,407.0) | |||
| ROMA (median, range) | ||||
| Overall | 5.0 (0.4-16.2) | 6.1 (0.5-99.3) | 72.9 (3.3-99.8) | <0.001 |
| FIGO stage I/II | 24.1 (3.7-91.8) | |||
| FIGO stage III/IV | 94.7 (3.3-99.8) |